https://www.prnewswire.co.uk/news-releases/targovax-to-host-key-opinion-leader-symposium-on-oncolytic-viruses-in-new-york-city-11-october-2018-694460851.html
Targovax to Host Key Opinion Leader Symposium on Oncolytic Viruses in New York City, 11 October 2018
/PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, is...
key opinion leadernew york cityoncolytic viruseshostsymposium
https://physiciansnews.com/2014/10/31/new-cancer-therapy-using-oncolytic-viruses-to-treat-metastatic-disease/
New Cancer Therapy: Using Oncolytic Viruses to Treat Metastatic Disease - Physicians News
Nov 3, 2014 - Although much research is being done to combat primary tumors, there exists a crucial need to find a treatment that can be effective against metastatic cancer.
cancer therapyoncolytic virusesmetastatic diseasenewusing